Interestingly, both AR antagonists and androgens at SAL can trigger cellular senescence in PCa in cell culture and ex vivo tumor samples [32,37], which might be one of the underlying mechanisms of AR ligand-mediated PCa growth inhibition. Here, AR is linked to neoplasm.